Skip to main content
. 2019 Feb 22;11(3):606–620. doi: 10.1080/19420862.2019.1578147

Figure 5.

Figure 5.

Comparison of the purity of HLX01, CN-rituximab and EU-rituximab. (a) SEC-HPLC chromatograms. The enlarged chromatograms are plotted on the right panel. The high molecular weight variants (HMW), monomer and low molecular weight variants (LMW) are separated. (b) Non-reduced CE-SDS chromatograms.